Cargando…

Exploring the molecular mechanism of Sishen Decoction in the treatment of rheumatoid arthritis

BACKGROUND: To explore the potential targets and mechanism of action of Sishen Decoction in the treatment of rheumatoid arthritis (RA) using a network pharmacology approach. METHODS: Firstly, we analyzed the differentially expressed genes in the Gene Expression Omnibus (GEO) database and constructed...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Jiannan, Zhao, Yeyu, Qi, Qing, Gao, Mingli, Yu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577749/
https://www.ncbi.nlm.nih.gov/pubmed/36267726
http://dx.doi.org/10.21037/atm-22-3888
_version_ 1784811828081065984
author Zheng, Jiannan
Zhao, Yeyu
Qi, Qing
Gao, Mingli
Yu, Jing
author_facet Zheng, Jiannan
Zhao, Yeyu
Qi, Qing
Gao, Mingli
Yu, Jing
author_sort Zheng, Jiannan
collection PubMed
description BACKGROUND: To explore the potential targets and mechanism of action of Sishen Decoction in the treatment of rheumatoid arthritis (RA) using a network pharmacology approach. METHODS: Firstly, we analyzed the differentially expressed genes in the Gene Expression Omnibus (GEO) database and constructed a protein-protein interaction (PPI) network using potential core target proteins determined by the STRING platform and Cytoscape software. We also performed gene ontology functional enrichment analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) signaling pathway analysis, and gene set enrichment analysis (GSEA) on the potential targets, and then used the disease target database to download targets related to RA pathogenesis. The relevant targets were intersected with the action targets of Sishen Decoction to obtain the potential targets considered for the treatment of RA with Sishen Decoction. RESULTS: The GSE55235 and GSE77298 datasets were downloaded from the GEO database for analysis, and 73 genes with abnormally high expression in RA and 26 genes with abnormally low expression in RA were obtained by taking the intersection of highly expressed genes and low expression genes in RA. The results of KEGG and Metascape showed that the differential genes were enriched in inflammation-related signaling pathways such as leukocyte migration, myeloid leukocyte-mediated immunity, and lymphocyte activation, as well as bone activation and bone development, which are closely related to RA. In the exploration of the drug targets of Sishen Decoction for the treatment of RA, it was found that Sishen Decoction may regulate the interleukin (IL)-17) signaling pathway, tumour necrosis factor (TNF) signaling pathway, and chemokine signaling pathway in RA by targeting MMP9 and CXCR4. CONCLUSIONS: This study explored the potential targets and signaling pathways of Sishen Decoction in the treatment of RA, which may help to illustrate the mechanisms involved in the action of Sishen Decoction and better understand its anti-RA role in the inhibition of angiogenesis, synovial proliferation, and bone destruction.
format Online
Article
Text
id pubmed-9577749
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-95777492022-10-19 Exploring the molecular mechanism of Sishen Decoction in the treatment of rheumatoid arthritis Zheng, Jiannan Zhao, Yeyu Qi, Qing Gao, Mingli Yu, Jing Ann Transl Med Original Article BACKGROUND: To explore the potential targets and mechanism of action of Sishen Decoction in the treatment of rheumatoid arthritis (RA) using a network pharmacology approach. METHODS: Firstly, we analyzed the differentially expressed genes in the Gene Expression Omnibus (GEO) database and constructed a protein-protein interaction (PPI) network using potential core target proteins determined by the STRING platform and Cytoscape software. We also performed gene ontology functional enrichment analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) signaling pathway analysis, and gene set enrichment analysis (GSEA) on the potential targets, and then used the disease target database to download targets related to RA pathogenesis. The relevant targets were intersected with the action targets of Sishen Decoction to obtain the potential targets considered for the treatment of RA with Sishen Decoction. RESULTS: The GSE55235 and GSE77298 datasets were downloaded from the GEO database for analysis, and 73 genes with abnormally high expression in RA and 26 genes with abnormally low expression in RA were obtained by taking the intersection of highly expressed genes and low expression genes in RA. The results of KEGG and Metascape showed that the differential genes were enriched in inflammation-related signaling pathways such as leukocyte migration, myeloid leukocyte-mediated immunity, and lymphocyte activation, as well as bone activation and bone development, which are closely related to RA. In the exploration of the drug targets of Sishen Decoction for the treatment of RA, it was found that Sishen Decoction may regulate the interleukin (IL)-17) signaling pathway, tumour necrosis factor (TNF) signaling pathway, and chemokine signaling pathway in RA by targeting MMP9 and CXCR4. CONCLUSIONS: This study explored the potential targets and signaling pathways of Sishen Decoction in the treatment of RA, which may help to illustrate the mechanisms involved in the action of Sishen Decoction and better understand its anti-RA role in the inhibition of angiogenesis, synovial proliferation, and bone destruction. AME Publishing Company 2022-09 /pmc/articles/PMC9577749/ /pubmed/36267726 http://dx.doi.org/10.21037/atm-22-3888 Text en 2022 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Zheng, Jiannan
Zhao, Yeyu
Qi, Qing
Gao, Mingli
Yu, Jing
Exploring the molecular mechanism of Sishen Decoction in the treatment of rheumatoid arthritis
title Exploring the molecular mechanism of Sishen Decoction in the treatment of rheumatoid arthritis
title_full Exploring the molecular mechanism of Sishen Decoction in the treatment of rheumatoid arthritis
title_fullStr Exploring the molecular mechanism of Sishen Decoction in the treatment of rheumatoid arthritis
title_full_unstemmed Exploring the molecular mechanism of Sishen Decoction in the treatment of rheumatoid arthritis
title_short Exploring the molecular mechanism of Sishen Decoction in the treatment of rheumatoid arthritis
title_sort exploring the molecular mechanism of sishen decoction in the treatment of rheumatoid arthritis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577749/
https://www.ncbi.nlm.nih.gov/pubmed/36267726
http://dx.doi.org/10.21037/atm-22-3888
work_keys_str_mv AT zhengjiannan exploringthemolecularmechanismofsishendecoctioninthetreatmentofrheumatoidarthritis
AT zhaoyeyu exploringthemolecularmechanismofsishendecoctioninthetreatmentofrheumatoidarthritis
AT qiqing exploringthemolecularmechanismofsishendecoctioninthetreatmentofrheumatoidarthritis
AT gaomingli exploringthemolecularmechanismofsishendecoctioninthetreatmentofrheumatoidarthritis
AT yujing exploringthemolecularmechanismofsishendecoctioninthetreatmentofrheumatoidarthritis